Zoricon Pharmaceuticals Private Limited, a struck off private limited company, was established on 16 April 2004 in Indore, Madhya Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233MP2004PTC016550. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Prasanna Mandalgi (Director), Ranjana Mandalgi (Director), Surendra Bapat (Additional Director). It holds no open charges and ₹2.20 M settled loans. Its latest AGM occurred on 30 September 2009, with the balance sheet filed on 31 March 2009. It is based at 104 Saraswati Apartment. 45-46 Brijeshwari Annex, Indore, Madhya Pradesh, 452001.
U24233MP2004PTC016550
016550
16 April 2004
₹0.50 M
₹0.50 M
Roc Gwalior
Unlisted
Struck Off
Explore comprehensive insights into Zoricon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prasanna Mandalgi | Director | 16 Apr 2004 | Current |
| Ranjana Mandalgi | Director | 16 Apr 2004 | Current |
| Surendra Bapat | Additional Director | 11 Jun 2010 | Current |
| Yeshwant Rao Maheshram | Additional Director | 01 Apr 2010 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Zoricon Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Zoricon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2007 | Syndicate Bank | ₹2.00 M | Satisfied |
| 27 Jul 2005 | Syndicate Bank | ₹0.20 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Zoricon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Zoricon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zoricon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 19 Mar 2007 via Charge ID 10047998 with Syndicate Bank was fully satisfied on 23 Apr 2015. was documented.
Surendra Bapat was appointed as a Additional Director was appointed as a Additional Director on 11 Jun 2010 & has been associated with this company since 15 years 6 months . was recorded as a recent event.
The activity Yeshwant Rao Maheshram was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2010 & has been associated with this company since 15 years 8 months . was completed.
Zoricon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2009 as per latest MCA records. was recorded as a recent event.
The activity Zoricon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2009 with Roc Gwalior. was completed.
The activity A charge with Syndicate Bank of Rs. 2.00 M registered on 19 Mar 2007 with Charge ID 10047998 was modified on 25 Oct 2007. was completed.
The CIN of Zoricon Pharmaceuticals Private Limited is U24233MP2004PTC016550.
Zoricon Pharmaceuticals Private Limited is headquartered at 104 Saraswati Apartment. 45-46 Brijeshwari Annex, Indore, Madhya Pradesh, 452001.
Zoricon Pharmaceuticals Private Limited was incorporated on 16 April 2004.
The current directors of Zoricon Pharmaceuticals Private Limited are
The primary industry of Zoricon Pharmaceuticals Private Limited is Chemicals.
Zoricon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Zoricon Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX